StemCells, Inc. yesterday announced that based on positive interim results, it has closed enrollment in its Phase I/II clinical trial for dry age-related macular degeneration in order to focus its efforts on a follow-on Phase II randomized, controlled proof-of-concept study, later this year.
http://ift.tt/1laUfLF
http://ift.tt/1laUfLF
No comments:
Post a Comment